NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002039

Registered date:03/06/2009

The influence of dialyzer membrane on microcirculation and inflammation in hemodialysis patients.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic renal failure
Date of first enrollment2009/03/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Patients of Group 1 will receive EVAL membrane for 12 months. Patients of Group 2 will receive vitamin E-coated PS membrane for 12 months.

Outcome(s)

Primary Outcomehs-CRP, IL-6, events of hypotension during hemodialysis, SPP and baPWV will be measured at 0, 3, 6, 9 and 12 months after study initiation.
Secondary Outcomeserum creatinine, serum pre-albumin, serum albumin, muscle volume and BMI will be measured at 0, 3, 6, 9 and 12 months after study initiation.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients who did not agree with participating this clinical study.

Related Information

Contact

public contact
Name Hayato Nishida
Address Japan
Telephone
E-mail hnishida331@yahoo.co.jp
Affiliation Yamagata University, Faculty of Medicine Department of Urology
scientific contact
Name Hayato Nishida
Address 2-2-2 iidanishi, Yamagata-city, Yamagata, Japan. Japan
Telephone 023-633-1122
E-mail
Affiliation Yamagata University, Faculty of Medicine Department of Urology